About Sinopia Biosciences
Sinopia Biosciences is a company based in San Diego (United States) founded in 2014. Sinopia Biosciences has raised $2.82 million across 17 funding rounds from investors including NIH, HHS and National Institute of Neurological Disorders and Stroke. Sinopia Biosciences offers products and services including LEADS Platform. Sinopia Biosciences operates in a competitive market with competitors including NantHealth, BioAge Labs, Perthera, Genedata and Ontoforce, among others.
- Headquarter San Diego, United States
- SectorsHealthcare
- Website sinopiabio.com
- Total Equity Funding$2.82M (USD)
in 17 rounds
- Latest Funding Round$2.82M (USD), Seed
Jun 2026
- InvestorsNIH
& 3 more
Products & Services of Sinopia Biosciences
Sinopia Biosciences offers a comprehensive portfolio of products and services, including LEADS Platform.
AI-driven platform for screening and identifying novel drug targets using multi-omics.
Funding Insights of Sinopia Biosciences
Sinopia Biosciences has successfully raised a total of $2.82M across 17 strategic funding rounds. The most recent funding activity was a Seed round of $2.82 million completed in June 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2.82M
- Total Rounds 17
- Last Round Seed — $2.82M
- First Round $150,000
(Aug 2014)
- Investors Count 4
Latest 10 of 17 funding rounds of Sinopia Biosciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
4 investors in total: 4 institutional.
Investors in Sinopia Biosciences
Sinopia Biosciences has secured backing from 4 investors, including institutional investors. Prominent investors backing the company include NIH, HHS and National Institute of Neurological Disorders and Stroke.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Drug discovery services are provided to the biopharma sector. | 1887 | nih.gov | United States | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - | |
Research on neurological disorders and stroke is conducted and funded. | – | ninds.nih.gov | Bethesda, United States | |
- | – | nigms.nih.gov | - |
Investor details for Sinopia Biosciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Sinopia Biosciences
3 dated milestones of Sinopia Biosciences across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Sinopia Biosciences is founded.
- Funding First funding round of $150K.
- Funding Latest funding round, Seed, of $2.8M.
Competitors of Sinopia Biosciences
Sinopia Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NantHealth, BioAge Labs, Perthera, Genedata and Ontoforce, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| nanthealth.com | 2007 | El Segundo, United States | $607.58M | 380 | Bioinformatics platforms are provided for cancer treatment identification. | |
| bioagelabs.com | 2015 | Vallejo, United States | $293.9M | 43 | Bioinformatics platform is provided for biomarkers and drug discovery. | |
| perthera.com | 2012 | Mclean, United States | $17.02M | 13 | Molecular cancer profiling is conducted via genomics and proteomics. | |
| genedata.com | 1997 | Basel, Switzerland | – | 66 | Software solutions are developed for drug discovery and life sciences. | |
| ontoforce.com | 2011 | Ghent, Belgium | $9.13M | 31 | Semantic search platform is provided for pharmaceutical and biotech research. | |
| dandelionhealth.ai | 2020 | New York, United States | $15.89M | – | AI-powered real-world data platform is provided for clinical development. | |
| airfinity.com | 2015 | London, United Kingdom | – | 57 | Predictive data analysis software is developed for researchers. | |
| syntekabio.com | 2009 | Sunnyvale, United States | $11.12M | – | Life science-specific software and services are provided by Syntekabio. | |
| roam.io | 2013 | Dallas, United States | – | – | Cloud-based interactive digital signage solutions are provided for offline retailers. |
Detailed competitors of Sinopia Biosciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Sinopia Biosciences
The website of Sinopia Biosciences (sinopiabio.com) receives about 1.9K visits a month.
- Monthly visits1.9K
▼ 23.7% vs previous month
Latest news on Sinopia Biosciences
Complete news archive for Sinopia Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Sinopia Biosciences
10 companies that operate in the same segment as Sinopia Biosciences (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Sinopia Biosciences
Sinopia Biosciences was founded in 2014.
Sinopia Biosciences is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Sinopia Biosciences is a funded company, having raised a total of $2.82M across 17 funding rounds to date. The company's 1st funding round was a Grant of $3.3M, raised on Aug 2014.
Sinopia Biosciences was founded in 2014 in San Diego, United States, within the biotechnology sector. A proprietary systems biology and bioinformatics platform has been developed by the company to evaluate therapeutic safety through detailed biochemical analysis. Pathways linked to drug-induced movement disorders have been identified, and repurposed therapeutics are being advanced to address these conditions. Changes in red blood cells and platelets during transfusion are also under investigation.
Sinopia Biosciences's top competitors include NantHealth, BioAge Labs and Genedata.
Sinopia Biosciences offers LEADS Platform.
Sinopia Biosciences has 4 investors. Key investors include NIH, HHS, National Institute of Neurological Disorders and Stroke, and National Institute of General Medical Sciences.